tiprankstipranks
Kaleido Biosciences Inc (KLDO)
OTHER OTC:KLDO
US Market
KLDO
Kaleido Biosciences
RESEARCH TOOLSreports
Want to see KLDO full AI Analyst Report?

Kaleido Biosciences (KLDO) Income Statement

196 Followers

Kaleido Biosciences Income Statement

Last quarter (Q4 2021), Kaleido Biosciences's total revenue was $492.00K, an increase of 102.47% from the same quarter last year. In Q4, Kaleido Biosciences's net income was $-21.12M. See Kaleido Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 1.10M$ 975.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.25M$ -54.99M$ -1.32M$ 0.00$ 0.00
Operating Expenses
$ 86.41M$ 23.88M$ 86.66M$ 60.68M$ 27.03M
Depreciation and Amortization
$ 2.58M$ 1.82M$ 1.32M$ 792.00K$ 316.00K
EBITDA
$ -85.09M$ -77.00M$ -84.04M$ -59.03M$ -26.70M
Operating Income
$ -87.67M$ -78.87M$ -86.66M$ -60.68M$ -27.03M
Other Income/Expenses
$ -2.62M$ -2.75M$ 329.00K$ -1.06M$ -529.00K
Pretax Income
$ -90.29M$ -81.62M$ -86.33M$ -61.74M$ -27.56M
Net Income
$ -90.29M$ -81.62M$ -85.01M$ -61.74M$ -27.56M
Per Share Metrics
Basic EPS
$ -2.16$ -2.44$ -3.31$ -2.10$ -1.23
Diluted EPS
$ -2.16$ -2.44$ -3.31$ -2.10$ -1.23
Weighted Average Shares Outstanding
 41.86M 33.45M 25.70M 29.39M 22.42M
Weighted Average Shares Outstanding (Diluted)
 41.86M 33.45M 25.70M 29.39M 22.42M
Currency in USD

Kaleido Biosciences Earnings and Revenue History